BioStem Technologies (BSEM)
OTHER OTC:BSEM
Want to see BSEM full AI Analyst Report?
Total Valuation
BioStem Technologies has a market cap or net worth of $67.56M. The enterprise value is $59.15M.
Market Cap$67.56M
Enterprise Value$59.15M
Share Statistics
BioStem Technologies has 16,338,436 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,338,436
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioStem Technologies’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -1.62%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-1.62%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee23.74M
Profits Per Employee-3.29M
Employee Count2
Asset Turnover0.95
Inventory Turnover1.13
Valuation Ratios
The current PE Ratio of BioStem Technologies is ―. BioStem Technologies’s PEG ratio is 0.08.
PE Ratio―
PS Ratio1.34
PB Ratio1.63
Price to Fair Value1.63
Price to FCF9.67
Price to Operating Cash Flow7.01
PEG Ratio0.08
Income Statement
In the last 12 months, BioStem Technologies had revenue of 47.48M and earned -6.58M in profits. Earnings per share was -0.39.
Revenue47.48M
Gross Profit44.22M
Operating Income-689.15K
Pretax Income-389.65K
Net Income-6.58M
EBITDA-469.73K
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was 9.94M and capital expenditures -3.35M, giving a free cash flow of 6.59M billion.
Operating Cash Flow9.94M
Free Cash Flow6.59M
Free Cash Flow per Share0.40
Dividends & Yields
BioStem Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.78
52-Week Price Change-65.47%
50-Day Moving Average4.70
200-Day Moving Average5.15
Relative Strength Index (RSI)42.33
Average Volume (3m)65.14K
Important Dates
BioStem Technologies upcoming earnings date is Aug 25, 2026, During Market Hours (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 25, 2026
Ex-Dividend Date―
Financial Position
BioStem Technologies as a current ratio of 4.12, with Debt / Equity ratio of 10.29%
Current Ratio4.12
Quick Ratio3.85
Debt to Market Cap0.05
Net Debt to EBITDA55.82
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioStem Technologies has paid 6.19M in taxes.
Income Tax6.19M
Effective Tax Rate-15.89
Enterprise Valuation
BioStem Technologies EV to EBITDA ratio is -79.87, with an EV/FCF ratio of 5.69.
EV to Sales0.79
EV to EBITDA-79.87
EV to Free Cash Flow5.69
EV to Operating Cash Flow3.77
Balance Sheet
BioStem Technologies has $29.55M in cash and marketable securities with $3.33M in debt, giving a net cash position of $26.22M billion.
Cash & Marketable Securities$29.55M
Total Debt$3.33M
Net Cash$26.22M
Net Cash Per Share$1.60
Tangible Book Value Per Share$2.32
Margins
Gross margin is 128.16%, with operating margin of -1.45%, and net profit margin of -13.86%.
Gross Margin128.16%
Operating Margin-1.45%
Pretax Margin-0.82%
Net Profit Margin-13.86%
EBITDA Margin-0.99%
EBIT Margin-1.45%
Analyst Forecast
The average price target for BioStem Technologies is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside44.93% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-77.14%
EPS Growth Forecast-158.58%